Shareholder nod to continue 75+ Independent Director

Management Changes View source PDF Explain this filing

BIOFILCHEM · price

Loading chart…

▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.

Price reactionminutes from the announcement price · days from the prior close

+0.9%Reaction day

₹32.10

prior close

₹32.11

announcement price

After-mkt

timing

Nifty Microcap 250market · in no size index; the smallest one is used+0.3%+0.6% vs market

Pharmaceuticals peers, median of 171sector-0.0%+1.0% vs sector

On the reaction day the stock moved 0.6 pts more than Nifty Microcap 250 and 1.0 pts more than its Pharmaceuticals peers, over the same two closes: a difference in percentage points, not a measure of what the filing did.

Minutes after the announcementfrom the announcement price · no benchmark

Stock

+0.0

10m

+0.0

15m

+0.0

30m

+0.0

Sessions after the filingfrom the prior close

StockMarketvs marketSectorvs sector

Reaction day

+0.9+0.3+0.6-0.0+1.0

Next day

-1.8-1.3-0.5-1.3-0.5

-0.7-0.3-0.4-0.6-0.1

-5.7-0.6-5.1-1.6-4.1

-9.2-1.8-7.3-2.5-6.7

-6.4-1.8-4.6-2.7-3.7

-5.2-0.8-4.5-2.2-3.0

15d

-5.7-4.1-1.6-6.1+0.3

-12.6-9.4-3.2-9.1-3.5

—————

UpDownMarket · Nifty Microcap 250Sector · Pharmaceuticals peers, median of 171Pending

Minute windows have no benchmark: there is no intraday index history to compare against.

AI summary

At the 41st AGM held on 23 Sep 2026, shareholders approved continuation of Mr. Ashok Kumar Ramawat (DIN 08818263) as Non-Executive Independent Director beyond age 75, as required under SEBI LODR Regulation 17(1A). He turns 75 on 27 Sep 2027. He holds a B.Sc., has 46 years of pharma industry experience, and is not related to any director or KMP.

Likely market impact

Routine governance compliance; no change in board composition or control. Neutral for shareholders.